The company is traded under the ticker ‘SYAB’. It debuted on the Frankfurt Stock Exchange with the first day of trading on Friday, 30th April 2021.
Synlab Group is an international company that provides laboratory and medical diagnostics services to a range of sectors, including healthcare, wellness, veterinary medicine, food, and transport. Headquartered in Munich, the company has a global presence and has over 400 laboratories across the world. Synlab's initial public offering (IPO) took place on April 2021, meaning that the company’s shares are available to be publicly traded. Read on to discover how to get involved with Synlab’s IPO and how to trade on newly listed Synlab shares with our award winning Next Generation trading platform*.
Synlab set its final IPO offer price at EUR 18.00 per share.
The total offer volume amounts to EUR 772 million. This is with the assumption of the full exercise of the Greenshoe option, which is a clause inserted in the agreement of an IPO that allows underwriters to purchase additional company shares, maximum 15%, at the offering price. With Greenshoe exercised, free float is expected to amount to 19% of outstanding share capital.
Synlab is considered as one of Europe’s largest clinical laboratory and medical diagnostic services companies, and achieved Group revenues of EUR 2.6 billion in 2020.
Measured by revenue and number of tests, Synlab is one of the largest clinical laboratory and medical diagnostic service providers in Europe. Here are some reasons why investors may be particularly interested in trading on Synlab’s IPO:
Seamlessly open and close trades, track your progress and set up alerts
It must be noted that trading on Synlab shares comes with risks that traders should be aware of. For example, Synlab aim to raise EUR 400m from the IPO in order to use the proceeds to repay part of its debt obligations that are currently outstanding. The plan is for the company to reduce the debt, but the fact that it has large outstanding debts must be information to consider when investing in the company. This information can have an impact on investor sentiment, which can have an effect on the company’s share price.
The possibility of over-valuation is also an important factor to consider. This can potentially result in its shares booming on its opening day, and then they can very possibly go the opposite direction and open at a lower price or decrease throughout the day.
It is important for traders to stay up to date with market news, especially in cases of updates that may cause a position to decline. You can find out more in our news and analysis section of the platform.
As a leader of providing services within several sectors, Synlab has a number of competitors, such as Neotron SpA, TUV, and Unilabs. Other competitors include NeoGenomics and Quest Diagnostics, both of which you can trade on our Next Generation platform while you wait for the company to complete the IPO process.
Register for an account today and once the shares are available on our platform, you will be able to spread bet or trade CFDs on Synlab’s share price. IPOs do not usually go live at the start of the trading session, as the exchange needs to undertake a price discovery phase to calculate the opening price. Therefore, look out for Synlab’s IPO going live a couple of hours into the UK trading session on the day.
Discover more of our platform features through our library of platform video guides. You can keep up to date with industry news with our news and insights section, which contains fundamental analysis reports from Morningstar and news updates from Reuters.
Where can I trade Synlab’s IPO?
Synlab’s IPO can be traded on with our online Next Generation trading platform.
When is Synlab’s IPO date?
Synlab’s IPO date is set to be the 30th April 2021 and it will be traded under the ticker ‘SYAB’, on the Frankfurt Stock Exchange.
What will Synlab’s share price be?
Synlab has set its final IPO offer price at EUR 18.00 per share, which will be traded on the Frankfurt Stock Exchange.
*No1 Web-Based Platform, ForexBrokers.com Awards 2020; Best Telephone & Best Email Customer Service, based on highest user satisfaction among spread betters, CFD & FX traders, Investment Trends 2020 UK Leverage Trading Report; Best Platform Features & Best Mobile/Tablet App, Investment Trends 2019 UK Leverage Trading Report.
**Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.